Pramlintide
Extension Study of Protocol DFA102 to Examine the Long-Term Safety, Tolerability, and Effect on Body Weight of Pramlintide Administered in Combination With Metreleptin
AstraZeneca · Phase 2 · Completed · Enrollment 274
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| 3 | Obesity or overweight | n/r | n/r | n/r | n/r |
| 4 | Obesity or overweight | n/r | n/r | n/r | n/r |